BEL 20 Dec '24 (BEZ24)
Seasonal Chart
Price Performance
See MorePeriod | Period Low | Period High | Performance | |
---|---|---|---|---|
1-Month | 4,117.50 +2.99% on 11/19/24 | | 4,292.00 -1.20% on 11/11/24 | -29.50 (-0.69%) since 11/01/24 |
3-Month | 4,117.50 +2.99% on 11/19/24 | | 4,350.50 -2.53% on 09/27/24 | +33.00 (+0.78%) since 09/02/24 |
Most Recent Stories
More NewsDespite Chipotle Mexican Grill's underperformance compared to its consumer cyclical sector peers over the past three months, analysts remain moderately optimistic about the stock's potential.
MicroStrategy stock rode the rally in Bitcoin, which came close to breaking above the $100,000 psychological resistance on Nov. 22.
KBW reportedly upgraded the stock to ‘Outperform’ from ‘Market perform,’ while raising its price target to $82 per share from $70, implying a nearly 14% upside from current levels
November turned out to be a banner month for U.S. stocks, buoyed by optimism surrounding President-elect Donald Trump's victory. The Dow Jones and the S&P 500 Index logged in the best month of 2024, having...
Construction Partners, Inc. ROAD or CPI, has been capturing the attention of investors over the past few months. This civil infrastructure company’s stock rose a whopping 73.1% over the past three months....
Immunocore's KIMMTRAK receives NHS funding for HLA-A*02:01-positive adults with metastatic uveal melanoma after NICE's recent recommendation.Quiver AI SummaryImmunocore has announced that KIMMTRAK (tebentafusp)...
The S&P 500 Index ($SPX ) (SPY ) today is down -0.22%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.23%. Stocks today are posting...
WW International, Inc. WW stock has shown a remarkable performance in the past three months, outpacing the S&P 500 and the industry. In the same time frame, WW has surged 66.8% compared with the industry’s...
NVIDIA Corporation NVDA has been a standout performer in 2024, with its stock rocketing nearly 180% year to date. This stellar rise puts NVIDIA at the forefront of the semiconductor industry, handily outpacing...
Esperion Therapeutics, Inc. ESPR announced that it has filed new drug submissions (NDSs) in Canada to seek approval for its once-daily, oral non-statin drugs Nexletol (bempedoic acid) and Nexlizet as a...